drug,score,moa
gdsc_Navitoclax,0.647,"Bcl-2 family inhibitor: esp Bcl-xL, Bcl-2 and Bcl-w"
gdsc_Linsitinib,0.624,IGF-1R inhibitor
gdsc_TL-2-105,0.608,Not Clinically Relevant
gdsc_Tubastatin A,0.585,Not Clinically Relevant
gdsc_SB52334,0.584,Not Clinically Relevant
gdsc_GSK1070916,0.565,Not Clinically Relevant
gdsc_GSK429286A,0.539,Not Clinically Relevant
gdsc_QL-XII-61,0.531,Not Clinically Relevant
gdsc_VX-702,0.527,Not Clinically Relevant
gdsc_GW-2580,0.507,Not Clinically Relevant
gdsc_BX-912,0.498,Not Clinically Relevant
gdsc_Rucaparib,0.496,"PARP inhibitor, inhibits DNA repair"
ctrp_linsitinib,0.449,IGF-1R inhibitor
ctrp_staurosporine,0.445,Not Clinically Relevant
ctrp_BRD-K99006945,0.444,Not Clinically Relevant
ctrp_tubastatin A,0.442,Not Clinically Relevant
ctrp_BRD-K34485477,0.435,Not Clinically Relevant
gdsc_GSK319347A,0.432,Not Clinically Relevant
ctrp_dabrafenib,0.431,Braf (V600E) inhibitor
ctrp_CCT036477,0.430,Not Clinically Relevant
gdsc_Amuvatinib,0.427,Not Clinically Relevant
ctrp_CIL55,0.427,Not Clinically Relevant
gdsc_NSC-87877,0.422,Not Clinically Relevant
ctrp_isoliquiritigenin,0.418,Not Clinically Relevant
gdsc_XMD13-2,0.416,Not Clinically Relevant
ctrp_XL765,0.414,PI3K/mTOR inhibitor
ctrp_avrainvillamide,0.413,Not Clinically Relevant
ctrp_ABT-737,0.413,Bcl-2/Bcl-xL inhibitor
ctrp_ML050,0.406,Not Clinically Relevant
ctrp_ML239,0.406,Not Clinically Relevant
ctrp_serdemetan,0.403,"(JNJ-26854165) Mdm2 antagonist, stabilizes p53"
ctrp_BRD-K88742110,0.401,Not Clinically Relevant
ctrp_BRD-K26531177,0.398,Not Clinically Relevant
ctrp_skepinone-L,0.395,Not Clinically Relevant
ctrp_IU1,0.394,Not Clinically Relevant
gdsc_Selisistat,0.393,SIRT1 inhibitor
ctrp_BRD-K51490254,0.393,Not Clinically Relevant
ctrp_BRD-K49290616,0.392,Not Clinically Relevant
ctrp_indisulam,0.391,"carbonic anhydrase inibitor and  CDK inhibitor, targets G1 by depleting cyclin E. inducing p53 and p21, and inhibiting CDK2"
ctrp_JW-55,0.390,Not Clinically Relevant
gdsc_Olaparib,0.389,PARP Inhibitor
ctrp_BRD-K29313308,0.386,Not Clinically Relevant
ctrp_chlorambucil,0.386,"alkylates and cross-links DNA, interfering with DNA replication and damaging the DNA"
ctrp_PF-4800567 hydrochloride,0.384,Not Clinically Relevant
ctrp_tretinoin,0.384,Retinoid
ctrp_BMS-195614,0.381,Not Clinically Relevant
ctrp_olaparib,0.381,PARP Inhibitor
ctrp_CAY10576,0.381,Not Clinically Relevant
ctrp_PLX-4720,0.379,Not Clinically Relevant
ctrp_16-beta-bromoandrosterone,0.379,Not Clinically Relevant
ctrp_BRD-K28456706,0.378,Not Clinically Relevant
gdsc_HG-5-88-01,0.377,Not Clinically Relevant
ctrp_BRD-K11533227,0.376,Not Clinically Relevant
ctrp_compound 1B,0.375,Not Clinically Relevant
ctrp_tipifarnib-P1,0.374,Not Clinically Relevant
ctrp_NSC30930,0.374,Not Clinically Relevant
gdsc_SB-505124,0.374,Not Clinically Relevant
ctrp_BRD-K29086754,0.373,Not Clinically Relevant
ctrp_ML203,0.372,Not Clinically Relevant
ctrp_barasertib,0.372,highly selective Aurora B kinase inhibitor
ctrp_PRIMA-1-Met,0.371,Not Clinically Relevant
ctrp_SR1001,0.369,Not Clinically Relevant
ctrp_epigallocatechin-3-monogallate,0.367,Not Clinically Relevant
ctrp_Compound 7d-cis,0.367,Not Clinically Relevant
ctrp_BMS-270394,0.365,Not Clinically Relevant
ctrp_foretinib,0.364,c-Met/VEGFR2 inhibitor
gdsc_Talazoparib,0.364,Not Clinically Relevant
ctrp_SZ4TA2,0.362,Not Clinically Relevant
ctrp_RG-108,0.361,Not Clinically Relevant
ctrp_itraconazole,0.361,"Anti-fungal, hedgehog antagonist"
ctrp_BRD-K13999467,0.361,Not Clinically Relevant
ctrp_Repligen 136,0.360,Not Clinically Relevant
ctrp_fingolimod,0.359,"sphingosine-1-phosphate receptor modulator, sequesters lymphocytes in lymph nodes, mostly used for treating multiple sclerosis"
ctrp_PLX-4032,0.359,BRAF (V600E) inhibitor
ctrp_axitinib,0.359,"VEGFR, c-KIT and PDGFR inhibitor"
ctrp_BRD-K92856060,0.358,Not Clinically Relevant
ctrp_tacrolimus,0.357,"FK-506, immunosuppressive drug usedafter allogeneic organ transplant"
ctrp_BRD1835,0.357,Not Clinically Relevant
ctrp_BRD-K24690302,0.356,Not Clinically Relevant
ctrp_BRD-M00053801,0.355,Not Clinically Relevant
ctrp_belinostat,0.353,HDAC inhibitor (PXD101)
ctrp_CIL41,0.351,Not Clinically Relevant
ctrp_Compound 1541A,0.350,Not Clinically Relevant
ctrp_BRD-A71883111,0.350,Not Clinically Relevant
ctrp_lenvatinib,0.350,"VEGFR inhibitor (VEGFR1, VEGFR2 and VEGFR3)"
ctrp_BRD-K84807411,0.350,Not Clinically Relevant
ctrp_Mdivi-1,0.348,Not Clinically Relevant
ctrp_BRD6340,0.347,Not Clinically Relevant
ctrp_TG-100-115,0.346,PI3Kγ/δ inhibitor
ctrp_elocalcitol,0.346,vitamin D receptor agonist
ctrp_ML162,0.345,Not Clinically Relevant
ctrp_NSC23766,0.345,Not Clinically Relevant
gdsc_KIN001-270,0.343,Not Clinically Relevant
ctrp_JW-74,0.343,Not Clinically Relevant
ctrp_BRD-K42260513,0.342,Not Clinically Relevant
gdsc_UNC1215,0.341,Not Clinically Relevant
ctrp_darinaparsin,0.341,organic arsenic compound composed of dimethylated arsenic linked to glutathione
ctrp_NSC 74859,0.339,Not Clinically Relevant
ctrp_AC55649,0.339,Not Clinically Relevant
ctrp_NSC95397,0.338,Not Clinically Relevant
ctrp_nilotinib,0.337,"inhibits the kinases BCR-ABL,[26] KIT, LCK, EPHA3, EPHA8, DDR1, DDR2, PDGFRB, MAPK11 and ZAK"
ctrp_bexarotene,0.336,"retinoid that selectively activates retinoid X receptors (RXRs), induces cell differentiation and apoptosis "
ctrp_BRD8899,0.335,Not Clinically Relevant
ctrp_PX-12,0.334,thioredoxin-1 (Trx-1) inhibitor
ctrp_SKI-II,0.334,Not Clinically Relevant
ctrp_UNC0638,0.334,Not Clinically Relevant
ctrp_ABT-199,0.333,Bcl2 inhibitor
ctrp_LY-2183240,0.333,Not Clinically Relevant
ctrp_sitagliptin,0.332,"used for Treating type 2 diabetes, works by increasing the amount of insulin released by your body"
ctrp_sildenafil,0.332,"Viagra, used to treat erectile dysfunction and pulmonary arterial hypertension"
ctrp_alisertib,0.331,Aurora A kinase inhibitor
ctrp_PF-184,0.331,Not Clinically Relevant
ctrp_BIBR-1532,0.330,Not Clinically Relevant
ctrp_bendamustine,0.329,alkylating agent
ctrp_AT-406,0.327,Not Clinically Relevant
ctrp_PDMP,0.326,Not Clinically Relevant
ctrp_BRD-K44224150,0.326,Not Clinically Relevant
ctrp_ELCPK,0.325,Not Clinically Relevant
ctrp_BRD-K51831558,0.324,Not Clinically Relevant
ctrp_pifithrin-mu,0.323,Not Clinically Relevant
ctrp_ML083,0.323,Not Clinically Relevant
gdsc_NPK76-II-72-1,0.322,Not Clinically Relevant
ctrp_etoposide,0.322,Topo II inhibitor
ctrp_BIX-01294,0.322,Not Clinically Relevant
gdsc_Cisplatin,0.321,Not Clinically Relevant
ctrp_KW-2449,0.320,"multi-kinase inhibitor, mostly for Flt3, modestly potent to FGFR1, Bcr-Abl and Aurora A;"
ctrp_968,0.319,Not Clinically Relevant
ctrp_ML006,0.319,Not Clinically Relevant
ctrp_tamoxifen,0.319,"ER antagonist prodrug; converted to 4-OHT and endoxifen in the liver; competes with estrogen for ER binding, inhibits transcription of estrogen target genes"
gdsc_Daporinad,0.318,"inhibits biosynthesis of (NAD+ from niacinamide (vitamin B3), which may deplete energy reserves in metabolically active tumor cells"
ctrp_cytarabine hydrochloride,0.318,Not Clinically Relevant
ctrp_MST-312,0.318,Not Clinically Relevant
ctrp_BRD-K37390332,0.317,Not Clinically Relevant
ctrp_ML031,0.317,Not Clinically Relevant
ctrp_BMS-754807,0.317,Not Clinically Relevant
ctrp_NVP-ADW742,0.317,Not Clinically Relevant
ctrp_tacedinaline,0.316,Not Clinically Relevant
ctrp_NSC19630,0.315,Not Clinically Relevant
ctrp_GMX-1778,0.315,Not Clinically Relevant
ctrp_SN-38,0.315,"Topo I inhibitor, active metabolite of irinotecan but 1000 times more active"
ctrp_topotecan,0.315,Topo I inhibitor
ctrp_BRD-K78574327,0.314,Not Clinically Relevant
ccle_LBW242,0.314,Not Clinically Relevant
ctrp_Ki8751,0.314,Not Clinically Relevant
ctrp_ceranib-2,0.314,Not Clinically Relevant
ctrp_NSC48300,0.312,Not Clinically Relevant
ctrp_BRD-K80183349,0.310,Not Clinically Relevant
ctrp_AZD4547,0.310,"FGFR-1,2 and 3 inhibitor"
ctrp_MGCD-265,0.309,"inhibitor of c-Met and VEGFR1/2/3, as well as Ron and Tie2"
ctrp_cucurbitacin I,0.308,Not Clinically Relevant
ctrp_tandutinib,0.307,"FLT3 antagonist, also inhibits PDGFR and c-Kit, "
ctrp_navitoclax,0.307,"Bcl-2 family inhibitor: esp Bcl-xL, Bcl-2 and Bcl-w"
ctrp_apicidin,0.307,Not Clinically Relevant
ctrp_SGX-523,0.307, Met inhibitor
ctrp_SB-225002,0.306,Not Clinically Relevant
ctrp_AZD1480,0.306,JAK2 inhibitor with some activity against JAK3 and Tyk2
ctrp_ISOX,0.305,Not Clinically Relevant
ctrp_manumycin A,0.305,Not Clinically Relevant
ctrp_KPT185,0.305,Not Clinically Relevant
ctrp_BRD-K02251932,0.305,Not Clinically Relevant
ctrp_tivozanib,0.304,VEGFR inhibitor
ctrp_cediranib,0.304,VEGFR inhibitor
ctrp_AZD6482,0.303,"PI3Kβ inhibitor, less active against PI3Kδ, PI3Kα and PI3Kγ "
ctrp_cabozantinib,0.303,"MET, AXL, VEGFR and RET inhibitor"
ctrp_BRD-K02492147,0.302,Not Clinically Relevant
ctrp_BRD-K30019337,0.302,Not Clinically Relevant
ctrp_BRD-K66532283,0.302,Not Clinically Relevant
ctrp_necrostatin-1,0.301,Not Clinically Relevant
ctrp_brivanib,0.301,"multitargeted tyrosine kinase inhibitor, esp VEGFR and FGFR"
ctrp_CIL70,0.300,Not Clinically Relevant
ctrp_BIRB-796,0.300,Not Clinically Relevant
ctrp_KU-55933,0.299,Not Clinically Relevant
ctrp_BRD-K61166597,0.299,Not Clinically Relevant
ctrp_isoevodiamine,0.299,Not Clinically Relevant
ctrp_JW-480,0.299,Not Clinically Relevant
ctrp_HLI 373,0.298,Not Clinically Relevant
ctrp_TGX-221,0.297,Not Clinically Relevant
gdsc_SN-38,0.297,"Topo I inhibitor, active metabolite of irinotecan but 1000 times more active"
ctrp_vorinostat,0.296,HDAC inhibitor (SAHA)
ctrp_FGIN-1-27,0.295,Not Clinically Relevant
ctrp_erastin,0.294,Not Clinically Relevant
ctrp_LBH-589,0.294,HDAC inhibitor
ctrp_BRD-K34222889,0.293,Not Clinically Relevant
ctrp_BRD1812,0.293,Not Clinically Relevant
ctrp_BRD-K90370028,0.292,Not Clinically Relevant
ctrp_vorapaxar,0.291," thrombin receptor (protease-activated receptor, PAR-1) antagonist based on the natural product himbacine"
ctrp_RO4929097,0.291,Notch (gamma secretase) inhibitor
ctrp_triazolothiadiazine,0.291,Not Clinically Relevant
ctrp_Compound 23 citrate,0.291,Not Clinically Relevant
ctrp_pazopanib,0.290,"KIT, FGFR, PDGFR and VEGFR inhibitor"
ctrp_GSK-3 inhibitor IX,0.290,Not Clinically Relevant
ctrp_PI-103,0.290,Not Clinically Relevant
ctrp_cyclophosphamide,0.290,"alkylating agent, nitrogen mustard family, works by disrupting the duplication of DNA and the creation of RNA (Cytoxan)"
gdsc_Vorinostat,0.290,HDAC inhibitor (SAHA)
ctrp_BRD-K27224038,0.290,Not Clinically Relevant
ctrp_MK-2206,0.288,Akt1/2/3 inhibitor
ctrp_GW-843682X,0.288,Not Clinically Relevant
ctrp_BRD-K85133207,0.287,Not Clinically Relevant
gdsc_MPS-1-IN-1,0.286,Not Clinically Relevant
ctrp_FQI-1,0.286,Not Clinically Relevant
ctrp_BRD-K17060750,0.286,Not Clinically Relevant
ctrp_teniposide,0.285,Topo II inhibitor
ctrp_nintedanib,0.285,"tyrosine-kinase inhibitor, targeting VEGFR, FGFR and PDGFR"
ctrp_GSK2636771,0.285,"PI3K beta inhibitor, >900-fold selectivity over PI3Kα/PI3Kγ and >10-fold over PI3Kδ. "
ctrp_NVP-TAE684,0.285,Not Clinically Relevant
ctrp_importazole,0.284,Not Clinically Relevant
ctrp_sunitinib,0.284,"VEGFR2, PDGFRb and c-kit inhibitor; also inhibits FLT3"
ctrp_YK 4-279,0.284,Not Clinically Relevant
ctrp_cimetidine,0.283,(Tagamet) Antacid and antihistamine
ctrp_NSC632839,0.282,Not Clinically Relevant
ctrp_PYR-41,0.282,Not Clinically Relevant
gdsc_YM201636,0.281,Not Clinically Relevant
ctrp_N9-isopropylolomoucine,0.281,Not Clinically Relevant
ctrp_GANT-61,0.281,Not Clinically Relevant
ctrp_gossypol,0.281,"Natural product, may function to inhibit Bcl2 family members"
ctrp_AM-580,0.281,Not Clinically Relevant
ctrp_necrosulfonamide,0.281,Not Clinically Relevant
gdsc_BMS-754807,0.280,Not Clinically Relevant
ctrp_dacarbazine,0.279,"alkylating agent, Dacarbazine works by methylating guanine at the O-6 and N-7 positions"
ctrp_CIL56,0.279,Not Clinically Relevant
gdsc_NSC-207895,0.278,Not Clinically Relevant
ctrp_mitomycin,0.278,"DNA Alkylator, works by cross-linking DNA and inhibiting DNA synthesis"
ctrp_semagacestat,0.278,Notch (gamma secretase) inhibitor
ctrp_niclosamide,0.278,"used to treat tapeworm infestations,  inhibits glucose uptake, oxidative phosphorylation, and anaerobic metabolism in the tapeworm"
ctrp_sorafenib,0.277,"VEGFR, PDGFR and Raf (c-Raf) inhibitor"
ctrp_STF-31,0.277,Not Clinically Relevant
ctrp_CAL-101,0.277,"Idelalisib,  PI3K/p110δ inhibitor"
ctrp_KU-0063794,0.277,Not Clinically Relevant
ctrp_ouabain,0.276,Not Clinically Relevant
ctrp_LRRK2-IN-1,0.276,Not Clinically Relevant
ctrp_neuronal differentiation inducer III,0.276,Not Clinically Relevant
ctrp_PL-DI,0.275,Not Clinically Relevant
ctrp_BRD-K96970199,0.275,Not Clinically Relevant
ctrp_QW-BI-011,0.274,Not Clinically Relevant
ctrp_pifithrin-alpha,0.274,Not Clinically Relevant
ctrp_QS-11,0.274,Not Clinically Relevant
ctrp_PIK-93,0.274,Not Clinically Relevant
ctrp_temozolomide,0.274,alkylating agent
ctrp_FQI-2,0.274,Not Clinically Relevant
ctrp_omacetaxine mepesuccinate,0.273,"natural product, protein translation inhibitor, used for myeloid leukemia"
ctrp_BRD-K70511574,0.272,Not Clinically Relevant
ctrp_BRD-K34099515,0.272,Not Clinically Relevant
ctrp_BMS-536924,0.272,Not Clinically Relevant
ctrp_parbendazole,0.272,Not Clinically Relevant
ctrp_curcumin,0.272,"Natural Product, component of turmeric, may function as HDAC inhibitor"
ctrp_rigosertib,0.272,"ON-01910, Plk-1 inhibitor"
ctrp_entinostat,0.272,HDAC inhibitor
ctrp_CD-1530,0.271,Not Clinically Relevant
ctrp_SU11274,0.271,Not Clinically Relevant
ctrp_KU-60019,0.270,Not Clinically Relevant
ctrp_cerulenin,0.270,Not Clinically Relevant
ctrp_quizartinib,0.270,Flt3 inhibitor
ctrp_fluvastatin,0.269,"HMG-CoA reductase inhibitor,"
ctrp_cytochalasin B,0.269,Not Clinically Relevant
ctrp_VX-680,0.269,"VX-680, pan-Aurora inhibitor, mostly against Aurora A, less potent towards Aurora B/C"
ctrp_silmitasertib,0.269,casein kinase 2 inhibitor 
ctrp_ML210,0.268,Not Clinically Relevant
ctrp_pitstop2,0.268,Not Clinically Relevant
ctrp_ciclopirox,0.268,antifungal agent for topical dermatologic treatment of superficial mycoses
ctrp_doxorubicin,0.268,"Topo II inhibitor, DNA intercalator"
ctrp_AT7867,0.267,Not Clinically Relevant
ctrp_GSK461364,0.267,"Plk1 inhibitor, less active against Plk2 and Plk3."
ctrp_CD-437,0.267,Not Clinically Relevant
ctrp_crizotinib,0.266,"ALK, ROS1 and MET inhibitor"
ctrp_SCH-529074,0.266,Not Clinically Relevant
ctrp_Ch-55,0.266,Not Clinically Relevant
ctrp_CHIR-99021,0.265,Not Clinically Relevant
ctrp_BRD-K94991378,0.265,Not Clinically Relevant
ctrp_bardoxolone methyl,0.264,Not Clinically Relevant
ctrp_tipifarnib-P2,0.264,Not Clinically Relevant
ctrp_BRD-K41334119,0.264,Not Clinically Relevant
gdsc_WIKI4,0.263,Not Clinically Relevant
ctrp_PRL-3 inhibitor I,0.263,Not Clinically Relevant
ctrp_ETP-46464,0.263,Not Clinically Relevant
ctrp_fulvestrant,0.262,selective estrogen receptor degrader (SERD)
ctrp_B02,0.262,Not Clinically Relevant
ctrp_KH-CB19,0.262,Not Clinically Relevant
ctrp_BRD-K75293299,0.261,Not Clinically Relevant
gdsc_Camptothecin,0.261,Not Clinically Relevant
ctrp_Bax channel blocker,0.261,Not Clinically Relevant
ctrp_CAY10618,0.260,Not Clinically Relevant
ctrp_MG-132,0.260,Not Clinically Relevant
ctrp_dexamethasone,0.260,"synthetic corticosteroid, used to reduce inflammation"
gdsc_UNC0638,0.260,Not Clinically Relevant
ccle_PF2341066,0.260,"ALK, ROS1 and MET inhibitor"
ctrp_KX2-391,0.260,Src inhibitor (peptidomimetic) that targets the peptide substrate site of Src
ctrp_BRD-K96431673,0.259,Not Clinically Relevant
ctrp_BRD-K86535717,0.259,Not Clinically Relevant
ctrp_purmorphamine,0.259,Not Clinically Relevant
ctrp_pluripotin,0.259,Not Clinically Relevant
ctrp_BRD-K35604418,0.258,Not Clinically Relevant
ctrp_vincristine,0.258,"binds tubulin, disrupts microtubule dynamics"
gdsc_TW 37,0.257,Not Clinically Relevant
ctrp_AZD7762,0.257, Chk1 / Chk2 inhibitor
ctrp_CIL55A,0.257,Not Clinically Relevant
ctrp_SRT-1720,0.256,Not Clinically Relevant
ctrp_BRD-K14844214,0.256,Not Clinically Relevant
ctrp_thalidomide,0.256,"interacts with the ubiquitin E3 ligase cereblon, targeting this enzyme to degrade the Ikaros transcription factors IKZF1 and IKZF3. Used for multiple myeloma"
ctrp_CR-1-31B,0.255,Not Clinically Relevant
gdsc_ZG-10,0.254,Not Clinically Relevant
ctrp_I-BET151,0.254,Not Clinically Relevant
ctrp_AGK-2,0.254,Not Clinically Relevant
ctrp_R428,0.254,Not Clinically Relevant
ctrp_parthenolide,0.253,Not Clinically Relevant
gdsc_QL-X-138,0.253,Not Clinically Relevant
ctrp_OSI-027,0.252,Not Clinically Relevant
ctrp_clofarabine,0.251,purine nucleoside antimetabolite
ctrp_nakiterpiosin,0.251,Not Clinically Relevant
ctrp_leptomycin B,0.251,Not Clinically Relevant
"ctrp_1S,3R-RSL-3",0.250,Not Clinically Relevant
ctrp_NVP-231,0.250,Not Clinically Relevant
ctrp_GSK1059615,0.250,PI3Kα/β/δ/γ and mTOR inhibitor
ctrp_PRIMA-1,0.249,Not Clinically Relevant
ctrp_ML311,0.249,Not Clinically Relevant
ctrp_blebbistatin,0.249,Not Clinically Relevant
ctrp_daporinad,0.248,"inhibits biosynthesis of (NAD+ from niacinamide (vitamin B3), which may deplete energy reserves in metabolically active tumor cells"
gdsc_CX-5461,0.248,Not Clinically Relevant
ctrp_regorafenib,0.248,VEGFR2-TIE2 inhibitor 
ccle_Irinotecan,0.248,"aka CPT-11, inhibitor of Topo I"
ctrp_TPCA-1,0.248,Not Clinically Relevant
ctrp_NVP-BSK805,0.247,Not Clinically Relevant
ctrp_salermide,0.247,Not Clinically Relevant
ctrp_alvocidib,0.247,"Flavopiridol, CDK inhibitor, works against CDK1, 2, 4, 6 and 9"
ctrp_SB-525334,0.246,Not Clinically Relevant
ctrp_BRD-K66453893,0.246,Not Clinically Relevant
ctrp_bleomycin A2,0.246,"Induces DNA strand breaks, inhibits incorporation of thymidine into DNA strands."
ctrp_ciclosporin,0.245,
ctrp_GSK525762A,0.245,Not Clinically Relevant
ctrp_CAY10594,0.245,Not Clinically Relevant
ctrp_3-Cl-AHPC,0.244,Not Clinically Relevant
ctrp_palmostatin B,0.244,Not Clinically Relevant
ctrp_tivantinib,0.244,Met inhibitor
ctrp_narciclasine,0.244,Not Clinically Relevant
ctrp_ZSTK474,0.243,"PI3K inhibitor, inhibits all four PI3K isoforms, but most active against PI3Kδ"
gdsc_JW-7-24-1,0.243,Not Clinically Relevant
ctrp_DBeQ,0.242,Not Clinically Relevant
gdsc_AR-42,0.242,Not Clinically Relevant
ctrp_prochlorperazine,0.242,"dopamine (D2) receptor antagonist, used for treatment of nausea and vertigo."
ctrp_CI-976,0.241,Not Clinically Relevant
ctrp_WZ8040,0.241,Not Clinically Relevant
ccle_AEW541,0.240,Not Clinically Relevant
gdsc_CAY10603,0.240,Not Clinically Relevant
ctrp_simvastatin,0.240,"HMG-CoA reductase inhibitor,"
ctrp_piperlongumine,0.240,Not Clinically Relevant
ctrp_momelotinib,0.239,JAK1 and JAK2 inhibitor
ctrp_TG-101348,0.238,JAK2 inhibitor
ctrp_BI-2536,0.238,"Plk1 inhibitor, less active against Plk2 and Plk3."
ctrp_JQ-1,0.238,Not Clinically Relevant
ctrp_SCH-79797,0.238,Not Clinically Relevant
ctrp_ML312,0.238,Not Clinically Relevant
ctrp_UNC0321,0.236,Not Clinically Relevant
ctrp_BRD-K45681478,0.235,Not Clinically Relevant
ctrp_nutlin-3,0.234,"Mdm2 antagonist, stabilizes p53 "
ctrp_PF-573228,0.234,Not Clinically Relevant
ctrp_CHM-1,0.234,Not Clinically Relevant
gdsc_OSI-027,0.234,Not Clinically Relevant
ctrp_temsirolimus,0.234,Not Clinically Relevant
ctrp_HBX-41108,0.233,Not Clinically Relevant
ctrp_BRD-A94377914,0.233,Not Clinically Relevant
ctrp_ML320,0.232,Not Clinically Relevant
ctrp_MK-0752,0.232,Notch (gamma secretase) inhibitor
ctrp_tamatinib,0.232,(R4060) inhibitor of IgE and IgG-mediated activation of Fc receptor signaling. Primary target is Syk
ctrp_tigecycline,0.231,antibiotic used to treat a number of bacterial infections
ctrp_obatoclax,0.230,Not Clinically Relevant
ctrp_MK-1775,0.230,Wee1 kinase inhibitor
gdsc_CUDC-101,0.230,Not Clinically Relevant
ctrp_BRD4132,0.229,Not Clinically Relevant
ctrp_GDC-0941,0.229,"Pictilisib, potent inhibitor of PI3Kα/δ, with modest selectivity against p110β (11-fold) and p110γ"
gdsc_Belinostat,0.228,HDAC inhibitor (PXD101)
ctrp_WP1130,0.228,Not Clinically Relevant
ctrp_WZ4002,0.227,Not Clinically Relevant
gdsc_PI-103,0.226,Not Clinically Relevant
ctrp_AZ-3146,0.226,Not Clinically Relevant
ctrp_phloretin,0.225,Not Clinically Relevant
ctrp_BRD-A02303741,0.225,Not Clinically Relevant
ctrp_paclitaxel,0.225,disrupts microtubule dynamics
ctrp_EX-527,0.224,SIRT1 inhibitor
ctrp_PHA-793887,0.224,"CDK inhibitor, esp CDK2, CDK5 and CDK7"
ctrp_PAC-1,0.222,Not Clinically Relevant
ctrp_masitinib,0.222,"tyrosine-kinase inhibitor used in the treatment of mast cell tumors in animals, specifically dogs"
ctrp_TW-37,0.222,Not Clinically Relevant
ctrp_oligomycin A,0.222,Not Clinically Relevant
ctrp_SMER-3,0.222,Not Clinically Relevant
ctrp_MLN2480,0.221,"TAK-580, pan-Raf kinase inhibitor"
ctrp_methylstat,0.220,Not Clinically Relevant
ctrp_SB-743921,0.220,kinesin spindle protein (KSP) inhibitor
ctrp_bortezomib,0.219,proteasome inhibitor (Velcade)
ctrp_GW-405833,0.218,Not Clinically Relevant
ctrp_docetaxel,0.216,inhibits microtubule dynamics; semi-synthetic analogue of paclitaxel
ctrp_dinaciclib,0.216,"CDK inhibitor, esp CDK1, 2, 5, and 9"
ctrp_neopeltolide,0.216,Not Clinically Relevant
ctrp_BRD9876,0.215,Not Clinically Relevant
ctrp_sirolimus,0.214,"rapamycin, mTOR inhibitor"
ccle_Topotecan,0.214,Topo I inhibitor
ctrp_pevonedistat,0.213,"(MLN4924), inhibitor of NEDD8-activating enzyme (NAE)"
ctrp_gemcitabine,0.213,"Nucleoside analog,incorporation into DNA creates an irreparable error that leads to inhibition of further DNA synthesis"
ctrp_SID 26681509,0.212,Not Clinically Relevant
ctrp_RAF265,0.211,inhibitor of C-Raf/B-Raf/B-Raf V600E
gdsc_Genentech Cpd 10,0.211,Not Clinically Relevant
ctrp_PF-3758309,0.211,Not Clinically Relevant
ctrp_NVP-BEZ235,0.209,PI3K/mTOR inhibitor
ctrp_lovastatin,0.208,"HMG-CoA reductase inhibitor,"
ctrp_AZD8055,0.205,mTOR inhibitor
ctrp_BMS-345541,0.204,Not Clinically Relevant
ctrp_LE-135,0.201,Not Clinically Relevant
ctrp_KU 0060648,0.198,Not Clinically Relevant
ctrp_BRD-K71935468,0.161,Not Clinically Relevant
ctrp_BRD-K30748066,0.148,Not Clinically Relevant
gdsc_Sepantronium bromide,-0.178,"YM155 (Sepantronium Bromide), survivin suppressant "
ctrp_methotrexate,-0.185,"antimetabolite, competitively inhibits dihydrofolate reductase (DHFR), inhibits synthesis of DNA, RNA, thymidylates, and proteins"
gdsc_THZ-2-102-1,-0.190,Not Clinically Relevant
ccle_Sorafenib,-0.196,"VEGFR, PDGFR and Raf (c-Raf) inhibitor"
ctrp_SNS-032,-0.197,"CDK inhibitor, esp CDK2 , 7 and 9 "
gdsc_QL-XII-47,-0.199,Not Clinically Relevant
ctrp_myricetin,-0.200,Not Clinically Relevant
gdsc_Nilotinib,-0.200,"inhibits the kinases BCR-ABL,[26] KIT, LCK, EPHA3, EPHA8, DDR1, DDR2, PDGFRB, MAPK11 and ZAK"
gdsc_Etoposide,-0.200,Topo II inhibitor
ctrp_BRD-K01737880,-0.202,Not Clinically Relevant
ctrp_StemRegenin 1,-0.207,Not Clinically Relevant
ccle_RAF265,-0.207,inhibitor of C-Raf/B-Raf/B-Raf V600E
ctrp_SNX-2112,-0.210,Not Clinically Relevant
ctrp_vandetanib,-0.211,"VEGFR, EGFR and RET inhibitor"
ccle_Paclitaxel,-0.212,disrupts microtubule dynamics
gdsc_Doxorubicin,-0.223,"Topo II inhibitor, DNA intercalator"
gdsc_Mitomycin-C,-0.225,"DNA Alkylator, works by cross-linking DNA and inhibiting DNA synthesis"
gdsc_GSK690693,-0.226,Not Clinically Relevant
ctrp_BRD-K33514849,-0.227,Not Clinically Relevant
ctrp_BEC,-0.228,Not Clinically Relevant
ccle_TAE684,-0.231,Not Clinically Relevant
ctrp_bafilomycin A1,-0.234,Not Clinically Relevant
ctrp_YM-155,-0.237,"YM155 (Sepantronium Bromide), survivin suppressant "
gdsc_Dacinostat,-0.237,Not Clinically Relevant
ccle_L-685458,-0.237,Not Clinically Relevant
ctrp_MLN2238,-0.238,"Ixazomib, Proteasome inhibitor, inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome "
gdsc_Gemcitabine,-0.240,"Nucleoside analog,incorporation into DNA creates an irreparable error that leads to inhibition of further DNA synthesis"
gdsc_SB590885,-0.240,Not Clinically Relevant
ccle_AZD0530,-0.241,"kinase inhibitor, with selectivity against Src and Bcr-Abl"
ctrp_BRD8958,-0.242,Not Clinically Relevant
ctrp_pyrazolanthrone,-0.243,Not Clinically Relevant
gdsc_Entinostat,-0.243,HDAC inhibitor
ccle_TKI258,-0.246,Not Clinically Relevant
gdsc_THZ-2-49,-0.246,Not Clinically Relevant
ccle_PD-0332991,-0.246,CDK4/6 inhibitor
ctrp_avicin D,-0.246,Not Clinically Relevant
ctrp_PF-750,-0.246,Not Clinically Relevant
ctrp_bosutinib,-0.247,"BCR-Abl, Src, Lyn and Hck inhibitor"
gdsc_JQ1,-0.247,Not Clinically Relevant
ctrp_brefeldin A,-0.247,Not Clinically Relevant
ctrp_SR-II-138A,-0.247,Not Clinically Relevant
gdsc_BX796,-0.247,Not Clinically Relevant
ctrp_BRD-K55116708,-0.248,Not Clinically Relevant
gdsc_DMOG,-0.249,Not Clinically Relevant
ctrp_BRD-K48334597,-0.250,Not Clinically Relevant
gdsc_Vinorelbine,-0.251,Not Clinically Relevant
ctrp_BRD-K09344309,-0.252,Not Clinically Relevant
ctrp_BRD-K63431240,-0.252,Not Clinically Relevant
ctrp_saracatinib,-0.253,"kinase inhibitor, with selectivity against Src and Bcr-Abl"
ctrp_triptolide,-0.253,"diterpenoid epoxide from thunder god vine, may act on the XBP helicase that is a part of the TFIIH transcription factor complex"
ctrp_betulinic acid,-0.253,Not Clinically Relevant
gdsc_SNX-2112,-0.254,Not Clinically Relevant
ccle_17-AAG,-0.255,Not Clinically Relevant
ctrp_BYL-719,-0.255,PI3Kα inhibitor with minimal effect on PI3Kβ/γ/δ
ctrp_veliparib,-0.256,PARP inhibitor.
gdsc_Lestauritinib,-0.256,Not Clinically Relevant
gdsc_IPA-3,-0.257,Not Clinically Relevant
ctrp_BRD-K97651142,-0.257,Not Clinically Relevant
ctrp_LY-2157299,-0.257,Not Clinically Relevant
ccle_ZD-6474,-0.257,"VEGFR, EGFR and RET inhibitor"
gdsc_CP466722,-0.258,Not Clinically Relevant
ctrp_tosedostat,-0.259,inhibitor of the M1 family of aminopeptidases
ctrp_canertinib,-0.259,"pan-ErbB inhibitor for EGFR and ErbB2,  no activity to PDGFR, FGFR, InsR, PKC, or CDK1/2/4. "
ctrp_tanespimycin,-0.260,HSP90 inhibitor
ctrp_VU0155056,-0.260,Not Clinically Relevant
ctrp_gefitinib,-0.260,EGFR inhibitor (Iressa)
ctrp_C6-ceramide,-0.260,Not Clinically Relevant
ctrp_BRD-A86708339,-0.260,Not Clinically Relevant
gdsc_NG-25,-0.260,Not Clinically Relevant
ctrp_marinopyrrole A,-0.260,Not Clinically Relevant
ccle_Nutlin-3,-0.261,"Mdm2 antagonist, stabilizes p53 "
gdsc_Phenformin,-0.261,Anti-diabetic AMPK Activator - mTOR Inhibitor - Autophagy inducer
ctrp_selumetinib,-0.261,MEK1 inhibitor
ctrp_neratinib,-0.261,Her2 and EGFR inhibitor
ccle_PHA-665752,-0.263,Not Clinically Relevant
gdsc_Methotrexate,-0.264,"antimetabolite, competitively inhibits dihydrofolate reductase (DHFR), inhibits synthesis of DNA, RNA, thymidylates, and proteins"
gdsc_Imatinib,-0.266,"Bcr-abl, c-kit and PDGFR inhibitor"
ctrp_spautin-1,-0.267,Not Clinically Relevant
gdsc_Epothilone B,-0.269,Not Clinically Relevant
ctrp_SJ-172550,-0.269,Not Clinically Relevant
gdsc_BAY-61-3606,-0.270,Not Clinically Relevant
gdsc_GSK650394,-0.270,Not Clinically Relevant
ctrp_BRD-K48477130,-0.272,Not Clinically Relevant
ctrp_Ko-143,-0.272,Not Clinically Relevant
ctrp_KHS101,-0.272,Not Clinically Relevant
gdsc_5-Fluorouracil,-0.273,antimetabolite
ctrp_fluorouracil,-0.273,antimetabolite
ctrp_BRD-K64610608,-0.274,Not Clinically Relevant
ctrp_valdecoxib,-0.274,"NSAID used in the treatment of osteoarthritis, rheumatoid arthritis"
ccle_PD-0325901,-0.274,Not Clinically Relevant
gdsc_Elesclomol,-0.275,Not Clinically Relevant
ctrp_ML258,-0.275,Not Clinically Relevant
gdsc_TL-1-85,-0.275,Not Clinically Relevant
gdsc_XMD8-92,-0.276,Not Clinically Relevant
gdsc_Pyrimethamine,-0.277,Not Clinically Relevant
ccle_Lapatinib,-0.277,HER2/EGFR inhibitor
ccle_Panobinostat,-0.277,HDAC inhibitor
ctrp_BRD-K71781559,-0.278,Not Clinically Relevant
ctrp_ifosfamide,-0.278,"alkylating agent, nitrogen mustard family, works by disrupting the duplication of DNA and the creation of RNA"
ctrp_Merck60,-0.278,Not Clinically Relevant
gdsc_YK-4-279,-0.278,Not Clinically Relevant
ctrp_OSI-930,-0.279," inhibitor of Kit, KDR and CSF-1R; also potent to Flt-1, c-Raf and Lck"
ctrp_BRD-A05715709,-0.279,Not Clinically Relevant
ctrp_ML334 diastereomer,-0.281,Not Clinically Relevant
ctrp_fumonisin B1,-0.281,Not Clinically Relevant
ctrp_GSK-J4,-0.281,Not Clinically Relevant
ctrp_cyanoquinoline 11,-0.281,Not Clinically Relevant
gdsc_Erlotinib,-0.281,EGFR inhibitor (Tarceva)
gdsc_Vinblastine,-0.283,"disrupts microtubule dynamics; vinca alkaloid, chemical analogue of vincristine"
ctrp_austocystin D,-0.283,Not Clinically Relevant
gdsc_Shikonin,-0.284,Not Clinically Relevant
ctrp_AT13387,-0.285,Selective potent Hsp90 inhibitor
ctrp_HC-067047,-0.285,Not Clinically Relevant
ctrp_NPC-26,-0.285,Not Clinically Relevant
ctrp_GDC-0879,-0.285,Not Clinically Relevant
ctrp_FSC231,-0.286,Not Clinically Relevant
ctrp_VAF-347,-0.286,Not Clinically Relevant
gdsc_GW843682X,-0.287,Not Clinically Relevant
ctrp_MI-1,-0.287,Not Clinically Relevant
gdsc_Seliciclib,-0.287,Not Clinically Relevant
gdsc_Omipalisib,-0.287,Not Clinically Relevant
ctrp_BRD-K33199242,-0.289,Not Clinically Relevant
gdsc_Fedratinib,-0.289,JAK2 inhibitor
gdsc_WZ3105,-0.289,Not Clinically Relevant
ctrp_lapatinib,-0.290,HER2/EGFR inhibitor
ctrp_WAY-362450,-0.290,Not Clinically Relevant
ctrp_AZD7545,-0.290,Not Clinically Relevant
gdsc_ZM447439,-0.290,Not Clinically Relevant
ctrp_CID-5951923,-0.291,Not Clinically Relevant
gdsc_PFI-1,-0.291,Not Clinically Relevant
ctrp_BCL-LZH-4,-0.292,Not Clinically Relevant
ctrp_BRD-K27986637,-0.292,Not Clinically Relevant
ctrp_linifanib,-0.292,"RTK inhibitor, targets VEGFR, PDGFR, KDR, and CSF-1R"
ctrp_COL-3,-0.293,matrix metalloproteinase (MMP) inhibitor
gdsc_HG-5-113-01,-0.293,Not Clinically Relevant
gdsc_ZSTK474,-0.293,"PI3K inhibitor, inhibits all four PI3K isoforms, but most active against PI3Kδ"
ctrp_VER-155008,-0.293,Not Clinically Relevant
ctrp_pandacostat,-0.295,Not Clinically Relevant
gdsc_KIN001-244,-0.295,Not Clinically Relevant
gdsc_AZD7762,-0.295, Chk1 / Chk2 inhibitor
gdsc_PIK-93,-0.296,Not Clinically Relevant
ctrp_BRD-K50799972,-0.297,Not Clinically Relevant
gdsc_Lapatinib,-0.298,HER2/EGFR inhibitor
gdsc_BI-2536,-0.298,"Plk1 inhibitor, less active against Plk2 and Plk3."
gdsc_A-443654,-0.299,Not Clinically Relevant
gdsc_JQ12,-0.299,Not Clinically Relevant
ccle_PLX4720,-0.300,Not Clinically Relevant
ctrp_nelarabine,-0.301,"purine nucleoside analog, which causes inhibition of DNA synthesis and cytotoxicity"
gdsc_Cytarabine,-0.301,"antimetabolite, causes DNA damage,  inhibits both DNA and RNA polymerases and nucleotide reductase enzymes needed for DNA synthesis"
ctrp_dasatinib,-0.302,"BCR-Abl, Src, c-Kit inhibitor"
gdsc_CCT-018159,-0.302,Not Clinically Relevant
gdsc_AT-7519,-0.302,Not Clinically Relevant
ctrp_decitabine,-0.302,"Nucleoside analog, inhibitor of DNA methylation and DNA synthesis (Dacogen)"
ccle_Nilotinib,-0.302,"inhibits the kinases BCR-ABL,[26] KIT, LCK, EPHA3, EPHA8, DDR1, DDR2, PDGFRB, MAPK11 and ZAK"
ctrp_BRD-K16147474,-0.302,Not Clinically Relevant
ctrp_L-685458,-0.303,Not Clinically Relevant
gdsc_Palbociclib,-0.305,CDK4/6 inhibitor
ctrp_trametinib,-0.306,MEK inhibitor (MEK1 and MEK2)
ctrp_BRD-K04800985,-0.307,Not Clinically Relevant
gdsc_Dactolisib,-0.307,PI3K/mTOR inhibitor
gdsc_Luminespib,-0.308,Not Clinically Relevant
ctrp_hyperforin,-0.309,"Active ingredient in St. John's Wort, blocks reuptake of of serotonin, norepinephrine, dopamine and GABA"
ctrp_AA-COCF3,-0.309,Not Clinically Relevant
ctrp_myriocin,-0.309,Not Clinically Relevant
gdsc_Zibotentan,-0.310,Not Clinically Relevant
ctrp_azacitidine,-0.310,"Nucleoside analog, inhibitor of DNA methylation and DNA/RNA synthesis (Vidaza)"
gdsc_CMK,-0.311,Not Clinically Relevant
gdsc_(5Z)-7-Oxozeaenol,-0.312,Not Clinically Relevant
gdsc_OSU-03012,-0.312,Not Clinically Relevant
ccle_Erlotinib,-0.312,EGFR inhibitor (Tarceva)
gdsc_I-BET-762,-0.313,Not Clinically Relevant
gdsc_Piperlongumine,-0.314,Not Clinically Relevant
ctrp_A-804598,-0.314,Not Clinically Relevant
ctrp_trifluoperazine,-0.314,"antipsychotic, antiadrenergic and antidopaminergic. Blocks dopamine D1 and D2 receptors "
gdsc_Bleomycin,-0.314,"Induces DNA strand breaks, inhibits incorporation of thymidine into DNA strands."
ctrp_afatinib,-0.315,EGFR and ErbB2 inhibitor
gdsc_Docetaxel,-0.315,inhibits microtubule dynamics; semi-synthetic analogue of paclitaxel
gdsc_SGC0946,-0.316,Not Clinically Relevant
gdsc_Midostaurin,-0.316,Not Clinically Relevant
ctrp_GSK4112,-0.317,Not Clinically Relevant
ctrp_PD318088,-0.317,Not Clinically Relevant
gdsc_S-Trityl-L-cysteine,-0.318,Not Clinically Relevant
ctrp_erismodegib,-0.318,Hedgehog (Smoothened) antagonist (LDE225)
gdsc_BMS-345541,-0.318,Not Clinically Relevant
gdsc_Serdemetan,-0.318,"(JNJ-26854165) Mdm2 antagonist, stabilizes p53"
ccle_AZD6244,-0.320,MEK1 inhibitor
ctrp_BRD-K09587429,-0.320,Not Clinically Relevant
ctrp_ibrutinib,-0.320,BTK kinase inhibitor
gdsc_Embelin,-0.321,Not Clinically Relevant
ctrp_BRD-K52037352,-0.323,Not Clinically Relevant
gdsc_Thapsigargin,-0.324,Not Clinically Relevant
gdsc_GSK269962A,-0.324,Not Clinically Relevant
gdsc_AS605240,-0.324,Not Clinically Relevant
gdsc_Bleomycin (50 uM),-0.326,Not Clinically Relevant
gdsc_QL-VIII-58,-0.326,Not Clinically Relevant
ctrp_RITA,-0.328,Not Clinically Relevant
ctrp_lomeguatrib,-0.329,"Inhibitor of MGMT, a DNA repair protein that confers resistance to alkylating agents such as Temozolomide, DTIC, Carmustine, etc. "
ctrp_imatinib,-0.329,"Bcr-abl, c-kit and PDGFR inhibitor"
ctrp_isonicotinohydroxamic acid,-0.330,Not Clinically Relevant
ctrp_IC-87114,-0.330,Not Clinically Relevant
gdsc_AZD8055,-0.331,mTOR inhibitor
gdsc_PF-562271,-0.332,Not Clinically Relevant
ctrp_IPR-456,-0.332,Not Clinically Relevant
gdsc_PHA-793887,-0.332,"CDK inhibitor, esp CDK2, CDK5 and CDK7"
ctrp_CBB-1007,-0.333,Not Clinically Relevant
gdsc_Obatoclax Mesylate,-0.334,Not Clinically Relevant
gdsc_Ponatinib,-0.338,Bcr-abl inhibitor
ctrp_istradefylline,-0.338,"adenosine A2A receptor antagonist, useful in the treatment of Parkinson's disease"
gdsc_XMD11-85h,-0.338,Not Clinically Relevant
ctrp_procarbazine,-0.339,alkylating agent
gdsc_Pevonedistat,-0.339,"(MLN4924), inhibitor of NEDD8-activating enzyme (NAE)"
gdsc_PD0325901,-0.340,Not Clinically Relevant
gdsc_MK-2206,-0.341,Akt1/2/3 inhibitor
ctrp_PF-543,-0.342,Not Clinically Relevant
gdsc_Saracatinib,-0.343,"kinase inhibitor, with selectivity against Src and Bcr-Abl"
ctrp_necrostatin-7,-0.344,Not Clinically Relevant
ctrp_ML029,-0.344,Not Clinically Relevant
gdsc_LFM-A13,-0.345,Not Clinically Relevant
gdsc_JNK-9L,-0.345,Not Clinically Relevant
gdsc_WH-4-023,-0.345,Not Clinically Relevant
gdsc_Tamoxifen,-0.345,"ER antagonist prodrug; converted to 4-OHT and endoxifen in the liver; competes with estrogen for ER binding, inhibits transcription of estrogen target genes"
ctrp_ruxolitinib,-0.346,"JAK1/2 inhibitor, used for myelofibrosis and polycythemia vera"
ctrp_BRD-K41597374,-0.346,Not Clinically Relevant
gdsc_TGX221,-0.347,Not Clinically Relevant
gdsc_AICA Ribonucleotide,-0.347,Not Clinically Relevant
gdsc_Pictilisib,-0.347,"Pictilisib, potent inhibitor of PI3Kα/δ, with modest selectivity against p110β (11-fold) and p110γ"
ctrp_PD 153035,-0.349,Not Clinically Relevant
gdsc_EHT-1864,-0.349,Not Clinically Relevant
ctrp_BRD9647,-0.350,Not Clinically Relevant
gdsc_AKT inhibitor VIII,-0.350,Not Clinically Relevant
ctrp_MI-2,-0.352,Not Clinically Relevant
gdsc_KIN001-266,-0.353,Not Clinically Relevant
gdsc_Cabozantinib,-0.354,"MET, AXL, VEGFR and RET inhibitor"
ctrp_abiraterone,-0.354,steroidal CYP17A1 inhibitor and androgen synthesis inhibitor 
gdsc_Tipifarnib,-0.354,Not Clinically Relevant
gdsc_BMS-536924,-0.355,Not Clinically Relevant
gdsc_Enzastaurin,-0.355,Not Clinically Relevant
gdsc_FH535,-0.356,Not Clinically Relevant
gdsc_HG6-64-1,-0.356,Not Clinically Relevant
gdsc_MG-132,-0.356,Not Clinically Relevant
gdsc_AS601245,-0.359,Not Clinically Relevant
gdsc_Salubrinal,-0.359,Not Clinically Relevant
ctrp_SR8278,-0.359,Not Clinically Relevant
gdsc_Avagacestat,-0.360,Not Clinically Relevant
gdsc_TPCA-1,-0.360,Not Clinically Relevant
ctrp_BRD-K19103580,-0.361,Not Clinically Relevant
gdsc_Lenalidomide,-0.362,"derivative of thalidomide, which interacts with the ubiquitin E3 ligase cereblon, targeting this enzyme to degrade the Ikaros transcription factors IKZF1 and IKZF3. Used for multiple myeloma"
gdsc_Trametinib,-0.363,MEK inhibitor (MEK1 and MEK2)
gdsc_Paclitaxel,-0.365,disrupts microtubule dynamics
gdsc_Bicalutamide,-0.368,"antiandrogen, used to treat prostate cancer"
ctrp_zebularine,-0.368,Not Clinically Relevant
ctrp_etomoxir,-0.368,"agonist of PPARα, inhibitor of carnitine palmitoyltransferase-1 (CPT-1)"
gdsc_PF-4708671,-0.369,Not Clinically Relevant
ctrp_birinapant,-0.373,"SMAC mimetic, mostly to cIAP1, less potent against XIAP."
gdsc_Bortezomib,-0.374,proteasome inhibitor (Velcade)
gdsc_XMD8-85,-0.374,Not Clinically Relevant
gdsc_Refametinib,-0.374,Not Clinically Relevant
gdsc_A-770041,-0.375,Not Clinically Relevant
gdsc_NVP-BHG712,-0.375,Not Clinically Relevant
gdsc_SL0101,-0.376,Not Clinically Relevant
ctrp_erlotinib,-0.376,EGFR inhibitor (Tarceva)
gdsc_BMS-509744,-0.377,Not Clinically Relevant
ctrp_O-6-benzylguanine,-0.380,"guanine analog, binds the DNA repair enzyme O(6)-alkylguanine DNA alkyltransferase (AGT) resulting in inhibition of AGT-mediated DNA repair"
ctrp_sotrastaurin,-0.384,pan-PKC inhibitor
gdsc_XMD15-27,-0.384,Not Clinically Relevant
gdsc_OSI-930,-0.384," inhibitor of Kit, KDR and CSF-1R; also potent to Flt-1, c-Raf and Lck"
gdsc_Temozolomide,-0.385,alkylating agent
ctrp_SB-431542,-0.385,Not Clinically Relevant
gdsc_KU-55933,-0.387,Not Clinically Relevant
gdsc_Temsirolimus,-0.389,Not Clinically Relevant
gdsc_Doramapimod,-0.392,Not Clinically Relevant
gdsc_CHIR-99021,-0.392,Not Clinically Relevant
gdsc_Dasatinib,-0.394,"BCR-Abl, Src, c-Kit inhibitor"
gdsc_JNK Inhibitor VIII,-0.397,Not Clinically Relevant
gdsc_FTI-277,-0.398,Not Clinically Relevant
gdsc_FR-180204,-0.398,Not Clinically Relevant
gdsc_KIN001-236,-0.400,Not Clinically Relevant
gdsc_NU7441,-0.403,Not Clinically Relevant
gdsc_Ispinesib Mesylate,-0.403,Not Clinically Relevant
gdsc_CCT007093,-0.404,Not Clinically Relevant
gdsc_NVP-TAE684,-0.405,Not Clinically Relevant
gdsc_Masitinib,-0.406,"tyrosine-kinase inhibitor used in the treatment of mast cell tumors in animals, specifically dogs"
gdsc_Veliparib,-0.407,PARP inhibitor.
gdsc_STF-62247,-0.407,Not Clinically Relevant
gdsc_JW-7-52-1,-0.407,Not Clinically Relevant
gdsc_XAV939,-0.410,Not Clinically Relevant
gdsc_GSK1904529A,-0.415,Not Clinically Relevant
gdsc_BIX02189,-0.417,Not Clinically Relevant
gdsc_FMK,-0.418,Not Clinically Relevant
gdsc_SB216763,-0.421,Not Clinically Relevant
gdsc_CI-1040,-0.421,Not Clinically Relevant
gdsc_AZD6482,-0.425,"PI3Kβ inhibitor, less active against PI3Kδ, PI3Kα and PI3Kγ "
gdsc_681640,-0.428,Not Clinically Relevant
gdsc_Vismodegib,-0.431,Hedgehog (Smoothened) antagonist (GDC-0449)
gdsc_Sunitinib,-0.431,"VEGFR2, PDGFRb and c-kit inhibitor; also inhibits FLT3"
gdsc_CGP-60474,-0.433,Not Clinically Relevant
gdsc_Tanespimycin,-0.434,HSP90 inhibitor
gdsc_IOX2,-0.435,Not Clinically Relevant
gdsc_CGP-082996,-0.435,Not Clinically Relevant
gdsc_WHI-P97,-0.435,Not Clinically Relevant
gdsc_Bryostatin 1,-0.436,Not Clinically Relevant
gdsc_RO-3306,-0.437,Not Clinically Relevant
gdsc_TAK-715,-0.440,Not Clinically Relevant
gdsc_Z-LLNle-CHO,-0.442,Not Clinically Relevant
gdsc_PLX-4720,-0.445,Not Clinically Relevant
gdsc_PAC-1,-0.450,Not Clinically Relevant
gdsc_CP724714,-0.450,Not Clinically Relevant
gdsc_Tozasertib,-0.464,"VX-680, pan-Aurora inhibitor, mostly against Aurora A, less potent towards Aurora B/C"
gdsc_KIN001-260,-0.466,Not Clinically Relevant
gdsc_Bosutinib,-0.471,"BCR-Abl, Src, Lyn and Hck inhibitor"
gdsc_Pazopanib,-0.472,"KIT, FGFR, PDGFR and VEGFR inhibitor"
gdsc_Parthenolide,-0.478,Not Clinically Relevant
gdsc_QS11,-0.484,Not Clinically Relevant
gdsc_Rapamycin,-0.487,"rapamycin, mTOR inhibitor"
gdsc_Sorafenib,-0.487,"VEGFR, PDGFR and Raf (c-Raf) inhibitor"
gdsc_Bexarotene,-0.489,"retinoid that selectively activates retinoid X receptors (RXRs), induces cell differentiation and apoptosis "
gdsc_Axitinib,-0.490,"VEGFR, c-KIT and PDGFR inhibitor"
gdsc_Pelitinib,-0.492,Not Clinically Relevant
gdsc_XMD14-99,-0.498,Not Clinically Relevant
gdsc_Gefitinib,-0.502,EGFR inhibitor (Iressa)
gdsc_Y-39983,-0.505,Not Clinically Relevant
gdsc_T0901317,-0.516,Not Clinically Relevant
gdsc_QL-XI-92,-0.518,Not Clinically Relevant
gdsc_AZ628,-0.522,Not Clinically Relevant
gdsc_Selumetinib,-0.523,MEK1 inhibitor
gdsc_PD173074,-0.524,Not Clinically Relevant
gdsc_rTRAIL,-0.527,Not Clinically Relevant
gdsc_Dabrafenib,-0.530,Braf (V600E) inhibitor
gdsc_Tivozanib,-0.532,VEGFR inhibitor
gdsc_VNLG/124,-0.535,Not Clinically Relevant
gdsc_Afatinib,-0.539,EGFR and ErbB2 inhibitor
gdsc_GNF-2,-0.545,Not Clinically Relevant
gdsc_Idelalisib,-0.549,"Idelalisib,  PI3K/p110δ inhibitor"
gdsc_Cyclopamine,-0.553,Not Clinically Relevant
gdsc_Nutlin-3a (-),-0.553,Not Clinically Relevant
gdsc_WZ-1-84,-0.568,Not Clinically Relevant
gdsc_GW441756,-0.572,Not Clinically Relevant
gdsc_PHA-665752,-0.585,Not Clinically Relevant
gdsc_Quizartinib,-0.590,Flt3 inhibitor
gdsc_Cetuximab,-0.592,Not Clinically Relevant
gdsc_Ruxolitinib,-0.592,"JAK1/2 inhibitor, used for myelofibrosis and polycythemia vera"
gdsc_VX-11e,-0.593,Not Clinically Relevant
gdsc_Crizotinib,-0.598,"ALK, ROS1 and MET inhibitor"
gdsc_Tretinoin,-0.614,Retinoid
gdsc_Motesanib,-0.623,Not Clinically Relevant
gdsc_Alectinib,-0.680,"ALK inhibitor, used to treat non-small-cell lung cancer (NSCLC)"
gdsc_Linifanib,-0.723,"RTK inhibitor, targets VEGFR, PDGFR, KDR, and CSF-1R"
